Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.13p
   
  • Change Today:
    -0.11p
  • 52 Week High: 8.00
  • 52 Week Low: 1.00
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 177,235
  • Market Cap: £2.73m
  • RiskGrade: 429
  • Beta: 0.04

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Lorenzo Gallon, James Renwick McCullough, Erik Kristian Lium

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 1.13p
Change Today -0.11p
% Change -8.54 %
52 Week High 8.00
52 Week Low 1.00
Volume 177,235
Shares Issued 242.54m
Market Cap £2.73m
Beta 0.04
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.21% above the market average28.21% above the market average28.21% above the market average28.21% above the market average28.21% above the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Price Trend
97.59% below the market average97.59% below the market average97.59% below the market average97.59% below the market average97.59% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 27-Jun-2025

Time Volume / Share Price
09:35 169,195 @ 1.18p
09:30 800 @ 1.25p
09:12 436 @ 1.00p
08:32 3,998 @ 1.25p
08:32 100 @ 1.25p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page